Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.
Camila de Oliveira VazBruna de Moraes Mazetto FonsecaPedro Eduardo Nascimento Silva VasconcelosLarissa Brito BastosMaria Aparecida CursinoJúlia Coelho França QuintanilhaGabriela Lisiane Tripiquia Vechiatto MesquitaAna Paula Rosa Dos SantosBruna Cardoso JacinthoJosé Diogo OliveiraJoyce Annichino-BizzachiFernanda Andrade OrsiPublished in: Lupus (2021)
Despite the high adherence to treatment and knowledge of VKA therapy, self-perceived HRQOL is poor in patients with PAPS and is mainly affected by VKA therapy. Searching for better treatment options is warranted.